Edwards Lifesciences heart valve approved in Europe

Edwards Lifesciences Corp. received European approval to market its Edwards Sapien transcatheter aortic heart valve technology with the RetroFlex transfemoral delivery system. The valve, which is implanted through the leg in a minimally invasive procedure, is for patients with severe aortic heart valve stenosis who are not good candidates for conventional open-heart valve replacement surgery.

View Full Article in:

Orange County Business Journal (Irvine, Calif.) · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT